LONDON--(BUSINESS WIRE)--Sep 11, 2018-- analysts forecast the global rosacea treatment market to grow at a CAGR of over 2% during the forecast period, according to their latest market research report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180911005260/en/

Technavio has published a new market research report on the global rosacea treatment market from 2018-2022. (Graphic: Business Wire)

The use of topical treatment is one of the major trends being witnessed in the . Topical therapy is considered as the most convenient and preferred therapy for the treatment of rosacea. Most of the medications available in the market are topical medications. Customers are adopting topical medications because of two reasons. First, the treatment is effective as it directly interacts with affected area in patients with rosacea and second, other therapies are not as effective as topical therapies and sometimes are not convenient to use.

This report is available at a USD 1,000 discount for a limited time only:

According to Technavio analysts, one of the key factors contributing to the growth of the global rosacea treatment market is the emergence of strong pipeline:

Global rosacea treatment market: Emergence of strong pipeline

Pharmaceutical companies are conducting extensive research for the development of effective treatment options for rosacea. Several companies are conducting phase III research trials for their drugs. For instance, Foamix is conducting research on FMX 103, which is a topical minocycline foam 1.5%.

According to a senior analyst at Technavio, “In June 2018, Foamix completed the final enrollment and dosing in the phase III trial of FMX 103 for the treatment of moderate-to-severe papulopustular rosacea. Foamix is expecting the topline results from the phase III trial at the beginning of the fourth quarter of 2018.”

Global rosacea treatment market: Segmentation analysis

The global rosacea treatment market research report provides market segmentation by application (topical and oral) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

Of the two major applications, the topical segment held the largest market share in 2017, contributing to over 68% of the market. This application segment will dominate the global market throughout the forecast period.

The Americas accounted for the highest incremental growth, accounting for close to 47% share. It was followed by EMEA and APAC respectively.

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

Market ecosystem Market characteristics Market segmentation analysis

Market Sizing

Market definition Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

Regional comparison Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

Vendors covered Vendor classification Market positioning of vendors Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20180911005260/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL GENERAL HEALTH

SOURCE: Technavio Research

Copyright Business Wire 2018.

PUB: 09/11/2018 07:53 AM/DISC: 09/11/2018 07:53 AM

http://www.businesswire.com/news/home/20180911005260/en